ArticleMolecular cancer research : MCR2018
Chemokine Signaling Facilitates Early-Stage Breast Cancer Survival and Invasion through Fibroblast-Dependent Mechanisms.
Open access · bronzeAbstract read
In one paragraph
Article in Molecular cancer research : MCR, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.
0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.7field-weighted citation impact, top 8% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 58 citations in OpenAlex.
- Cytokines and cancer-associated fibroblasts.Journal of hematology & oncology · 2026Review
- Native chromatome profiling reveals hundreds of metabolic enzymes in the nucleus across tissues.Nature communications · 2026Article
- Distinguishing granulomatous lobular mastitis from breast cancer using a clinical-radiomics nomogram to improve diagnostic accuracy.Frontiers in oncology · 2026Article
- Cooperative CCL2/CCR2 and HGF/MET signaling enhances breast cancer growth and invasion associated with metabolic reprogramming.Cancer biology & therapy · 2025Article
- CCL2/CCR2 signaling pathway in tumorigenesis and metastasis (Review).Oncology letters · 2025Review
- MCP-1-CCR2-M2 macrophages axis contributes to diffuse large B-cell lymphoma progression and inhibits antitumor immune response.Scientific reports · 2025Article
- Review
- The Therapeutic Potential of Physical Exercise in Cancer: The Role of Chemokines.International journal of molecular sciences · 2024Review
- Complex Role of Regulatory T Cells (Tregs) in the Tumor Microenvironment: Their Molecular Mechanisms and Bidirectional Effects on Cancer Progression.International journal of molecular sciences · 2024Review
- From monocyte-derived macrophages to resident macrophages-how metabolism leads their way in cancer.Molecular oncology · 2024Review
- Crosstalk and plasticity driving between cancer-associated fibroblasts and tumor microenvironment: significance of breast cancer metastasis.Journal of translational medicine · 2023Review
- The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis.Cellular & molecular immunology · 2023Review
- HtrA2 Independently Predicts Poor Prognosis and Correlates with Immune Cell Infiltration in Hepatocellular Carcinoma.Journal of oncology · 2023Article
- Transcriptome analysis reveals differences in cell cycle, growth and migration related genes that distinguish fibroblasts derived from pre-invasive and invasive breast cancer.Frontiers in oncology · 2023Article
- Chemokines network in bone metastasis: Vital regulators of seeding and soiling.Seminars in cancer biology · 2022Review
- Regulation of growth, invasion and metabolism of breast ductal carcinoma through CCL2/CCR2 signaling interactions with MET receptor tyrosine kinases.Neoplasia (New York, N.Y.) · 2022Article
- Ductal Carcinoma In Situ of Breast: From Molecular Etiology to Therapeutic Management.Endocrinology · 2022Review
- Diallyl Trisulfide Induces Apoptosis in Breast Ductal Carcinoma In Situ Derived and Minimally Invasive Breast Cancer Cells.Nutrients · 2022Article
- Ductal Carcinoma in Situ: Molecular Changes Accompanying Disease Progression.Journal of mammary gland biology and neoplasia · 2022Review
- The types of tumor infiltrating lymphocytes are valuable for the diagnosis and prognosis of breast cancer.Frontiers in genetics · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 1 institution in 1 country.
Gage Brummer *Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas.
Diana S Acevedo *Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas.
Qingting HuDepartment of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas.
Mike PortscheDepartment of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas.
Wei Bin FangDepartment of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas.
Min YaoDepartment of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas.
Brandon ZindaDepartment of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas.
Megan MyersDepartment of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas.
Nehemiah AlvarezDepartment of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas.
Patrick FieldsDepartment of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas.
Yan HongDepartment of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas.
Fariba BehbodDepartment of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas.
Nikki ChengDepartment of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas. ncheng@kumc.edu.
University of Kansas Medical Center · US
Funding
Novel Approaches for the Control of Microbial PathogensP30GM103326 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI LUTKENHAUS, JOSEPH F · 2012 to 2016
$5.3MProgression of DCIS to Invasive Breast Cancer through CCR2 Chemokine SignalingR01CA172764 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI CHENG, NIKKI · 2013 to 2024
$4.2MIdentifying the Molecular and Cellular Basis of Invasive Phenotype in Human DCISR01CA207445 · NCI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BEHBOD, FARIBA · 2017 to 2019
$1.7MNCI NIH HHS R01 CA172764NCI NIH HHS R01 CA207445NIGMS NIH HHS P30 GM103326
Abstract
Ductal carcinoma
Indexed as
Aldehyde Dehydrogenase 1 FamilyAnimalsBreast NeoplasmsCarcinoma, Intraductal, NoninfiltratingChemokine CCL2Disease ProgressionFemaleFibroblastsGene Expression Regulation, NeoplasticHigh-Temperature Requirement A Serine Peptidase 2HumansIsoenzymesMiceNeoplasm InvasivenessNeoplasm StagingNeoplasm TransplantationAldehyde Dehydrogenase 1 FamilyALDH1A1 protein, humanALDH1A1 protein, mouseCCL2 protein, humanCCR2 protein, humanChemokine CCL2High-Temperature Requirement A Serine Peptidase 2HTRA2 protein, humanIsoenzymesReceptors, CCR2Retinal Dehydrogenase
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.